Rasio rega marang bathi Utah Med (UTMD)

Utah Medical Products (UTMD) operates in the protected neonatology and gynecology segment, where stable demand is decoupled from economic growth. The price indicator on the chart, with a value of 21.70, links this resilience to the profitability of unique patented products and strict compliance with FDA standards. High barriers to entry and a reputation as a reliable supplier protect the company from low-cost alternatives.

Global medical device sales of Utah Medical Products (UTMD) leave the company vulnerable to logistical disruptions and trade wars. Any interruptions in component supplies are immediately reflected in net income, directly impacting the P/E ratio. This multiple measures the cost of one dollar of annual earnings, determining the extent of the investor's premium paid for the asset. Analyzing the company's price-to-earnings ratio allows for an assessment of the business's resilience to macroeconomic shocks.